Delivery Order SPE2DB20D3103-SPE2DB26FL3Z7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,403.24 for Lantus SoloStar 100 Unit/mL 3mL insulin on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a delivery order valued at $1,252.93 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL vials, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 unit/mL, 3mL) with a ceiling value of $3,500.34 under a firm fixed price contract type. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and no set-aside designation was applied. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, valued at $1,113.75. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a $2,435.84 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin on September 23, 2025, with completion expected by September 24, 2025. This firm fixed-price contract represents a single delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 1 million units of Lantus SoloStar 100 Unit/ML 3ML insulin at a ceiling value of $1,429.34. The order, which is non-set-aside and competitively awarded, is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $13,175.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL formulations. The contract is firm fixed price with no set-aside designation and was competitively awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,119.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin medication, with a completion date of August 1, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside designation, and performance will...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL3Z7Delivery Order
The Defense Logistics Agency awarded a $9,503.98 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL in 3mL formulation) on October 27, 2025, with completion targeted for October 28, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The parent IDC vehicle enables the company to distribute medications, vaccines, medical devices, and specialized healthcare commodities globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This specific delivery order for Lantus insulin exemplifies the contractor's ongoing role in supplying essential diabetes management medications through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 10/27/25 |